Picture of Shin Nippon Biomedical Laboratories logo

2395 Shin Nippon Biomedical Laboratories Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Shin Nippon Biomedical Laboratories, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line3,0634,1768,1837,7606,974
Depreciation
Amortisation
Non-Cash Items-381-1,512-3,805-2,574-3,120
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-892896397-2,784-3,616
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities3,0184,7475,9534,0022,107
Capital Expenditures-1,230-1,118-1,614-4,956-8,605
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-225849-2,654-9751,698
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1,455-269-4,269-5,931-6,908
Financing Cash Flow Items-70.8-6.6-2.9533.9-2.95
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1,450-2,471-4,9126,2665,319
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1092,037-2,7314,6491,077